DELRAY BEACH, Fla., June 2, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (Nasdaq:PSID), a developer of medical technologies for diabetes management, clinical diagnostics and bio-threat detection, announced today that its newly acquired subsidiary MicroFluidic Systems (“MFSI”), a leader in biological testing and sample preparation applications, has qualified and submitted a new government contract proposal, bringing the Company’s total pipeline of potential new government contracts to over $37 million. The majority of the contracts MFSI has submitted for, or is in the process of submitting for, are scheduled to be awarded in 2011. The recent submission proposes a cartridge-based radiation dosimeter based on MFSI’s Dragonfly technology.
